315 related articles for article (PubMed ID: 17329141)
21. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
[TBL] [Abstract][Full Text] [Related]
22. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
23. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
[TBL] [Abstract][Full Text] [Related]
24. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
[TBL] [Abstract][Full Text] [Related]
25. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ
J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506
[TBL] [Abstract][Full Text] [Related]
26. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
[TBL] [Abstract][Full Text] [Related]
27. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
29. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.
Kamoda T; Nozue H; Matsui A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):290-4. PubMed ID: 17224001
[TBL] [Abstract][Full Text] [Related]
31. Treatment with insulin glargine does not suppress serum IGF-1.
Slawik M; Schories M; Busse Grawitz A; Reincke M; Petersen KG
Diabet Med; 2006 Jul; 23(7):814-7. PubMed ID: 16842489
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
[TBL] [Abstract][Full Text] [Related]
33. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
Lehtihet M; Efendic S; Brismar K
Clin Sci (Lond); 2008 Sep; 115(5):167-74. PubMed ID: 18208402
[TBL] [Abstract][Full Text] [Related]
34. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
35. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
[TBL] [Abstract][Full Text] [Related]
36. Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy.
Davidson S; Hod M; Merlob P; Shtaif B
Clin Endocrinol (Oxf); 2006 Nov; 65(5):586-92. PubMed ID: 17054458
[TBL] [Abstract][Full Text] [Related]
37. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
38. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
Loukovaara M; Leinonen P; Teramo K; Nurminen E; Andersson S; Rutanen EM
Diabet Med; 2005 Apr; 22(4):434-9. PubMed ID: 15787669
[TBL] [Abstract][Full Text] [Related]
39. Effect of glucocorticoid treatment on insulin like growth factor-I and its binding proteins in children with nephrotic syndrome.
Dong F; Zhou X; Pang N; Wei M
Chin Med J (Engl); 2002 Sep; 115(9):1383-5. PubMed ID: 12411118
[TBL] [Abstract][Full Text] [Related]
40. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
